Yasuhito Tanaka
Kumamoto University
983 Papers
7K Citations
Yasuhito Tanaka is an academic researcher from Kumamoto University. The author has contributed to research in topics: Hepatitis B virus & Medicine. The author has an hindex of 69, co-authored 870 publications. Previous affiliations of Yasuhito Tanaka include South Valley University & National Institute of Advanced Industrial Science and Technology.
Chat about Author
Papers
Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)(1).
Takeji Umemura,Takeji Umemura,Yasuhito Tanaka,Kendo Kiyosawa,Harvey J. Alter,J. Wai-Kuo Shih +5 more
TL;DR: On the basis of the sequences in the two open reading frames of SEN‐V DNA, the rate of synonymous substitutions was 7.32×10−4 per site per year, which is close to RNA viruses and higher than other DNA viruses, the SEN‐ V might be replicated by machinery with poor or no proofreading function.
45
Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication.
Abeer Elkady,Yasuhito Tanaka,Fuat Kurbanov,Fuminaka Sugauchi,Masaya Sugiyama,Anis Khan,Douaa Sayed,Ghada Moustafa,AbdEl-Rahman AbdEl-Hameed,Masashi Mizokami +9 more
TL;DR: Geographic diversity of HCV was revealed in this study in southern Egypt and more carriers of non‐4a variants had chronic hepatitis compared to carriers of 4a, while more patients with 4a had liver cirrhosis.
45
Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C.
Man-Fung Yuen,Scott Fung,Yasuhito Tanaka,Takanobu Kato,Masashi Mizokami,John Chi-Hang Yuen,Danny Ka-Ho Wong,He-Jun Yuan,Siu-Man Sum,Annie On-On Chan,Benjamin C.Y. Wong,Ching-Lung Lai +11 more
TL;DR: Though patients with subtype Ba had earlier HBeAg seroconversion, the liver biochemistry, HBV DNA levels in different phases of the disease, and the probability of development of cirrhosis-related complications were the same with genotypes Ba and C.
45
Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.
Aya Naiki-Ito,Taku Naiki,Hiroyuki Kato,Keitaro Iida,Toshiki Etani,Yuko Nagayasu,Shugo Suzuki,Yoriko Yamashita,Shingo Inaguma,Masaya Onishi,Yasuhito Tanaka,Takahiro Yasui,Satoru Takahashi +12 more
TL;DR: Investigation of the chemopreventive and chemotherapeutic potential of luteolin, a flavonoid with antioxidative properties, on prostate cancer, including castration-resistant prostate cancer shows results that indicate lutingolin inhibits CRPC by AR-V7 suppression through miR-8080, highlighting lutesolin and miR -8080 as promising therapeutic agents for this disease.
44
Relationship Between Displacement and Degenerative Changes of the Sesamoids in Hallux Valgus
Ryuhei Katsui,Norihiro Samoto,Akira Taniguchi,Manabu Akahane,Shinji Isomoto,Kazuya Sugimoto,Yasuhito Tanaka +6 more
TL;DR: Lateral shift of the tibial sesamoid increased in association with progression of the hallux valgus deformity and was associated with worsening degenerative change within the SMJ.